Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced the issuance of a ...
The new technology integrates active temperature regulation, precise optical path control, and a versatile form factor.
In downstream processing of biopharmaceutical products, protein aggregation presents one of the main risks in terms of ...
Learn more about whether Medpace Holdings, Inc. or Repligen Corporation is a better investment based on AAII's A+ Investor ...
Inno Madness Round 1 results are in! See which 32 startups made it to Round 2 and vote for the companies that should advance ...
CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRSKAN with significant ...
Trump’s nominee to lead the Centers for Medicare and Medicaid Services is entangled in another potential conflict of interest ...
Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief ...
Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai ...
Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is being studied in multiple Phase 2b clinical trials with read-outs ...
The Biopharmaceutical Development segment ... such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing ...
Two years after being fired, the founder of an eye drug development company formerly based in Farmington Hills is waging a proxy battle to take back control. Mina Sooch is a serial entrepreneur, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results